Nitric oxide, Nω-hydroxy-l-arginine and breast cancer

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 2, 2008, Pages 103-106

  Pervin, Shehla ^a   Singh, Rajan ^a,b   Chaudhuri, Gautam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DREW UNIVERSITY   (United States)

Author keywords

Apoptosis; Cytostasis; Nitric oxide; Protein translation

Indexed keywords

CELL CYCLE PROTEIN; N(G) HYDROXYARGININE; NITRIC OXIDE;

APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CELL PROLIFERATION; CYTOSTASIS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

APOPTOSIS; ARGININE; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; FEMALE; HUMANS; NITRIC OXIDE;

EID: 47049115757     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.04.016     Document Type: Review

References (22)

1. Jenkinson C.P., Grody W.W., and Cederbaum S.D. Comparative properties of arginases. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 114 1 (1996) 107-132
2. Pegg A.E., and McCann P.P. Polyamine metabolism and function. Am. J. Physiol. 243 5 (1982) 212-221
3. Fukuto J.M. Chemistry of N-hydroxy-l-arginine. Methods Enzymol. 268 (1996) 365-375
4. Daghigh F., Fukuto J.M., and Ash D.E. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-l-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun. 202 1 (1994) 174-180
5. Hecker M., Nematollahi H., Hey C., Busse R., and Racké K. Inhibition of arginase by NG-hydroxy-l-arginine in alveolar macrophages: implications for the utilization of l-arginine for nitric oxide synthesis. FEBS Lett. 359 2-3 (1995) 251-254
6. Boucher J.L., Custot J., Vadon S., Delaforge M., Lepoivre M., Tenu J.P., Yapo A., and Mansuy D. N-omega-hydroxyl-l-arginine, an intermediate in the l-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203 3 (1994) 1614-1621
7. Chanda R., and Ganguly A.K. Polyamines in relation to human breast, rectal and squamous cell carcinoma. Cancer Lett. 39 3 (1988) 311-318
8. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., and Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72 1 (1995) 41-44
9. Vakkala M., Kahlos K., Lakari E., Pääkkö P., Kinnula V., and Soini Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin. Cancer Res. 6 6 (2000) 2408-2416
10. Tse G.M.K., Wong F.C., Tsang A.K., Lee C.S., Lui P.C., Lo A.W., Law B.K., Scolyer R.A., Karim R.Z., and Putti T.C. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. J. Clin. Pathol. 58 6 (2005) 600-604
11. Singh R., Pervin S., Karimi A., Cederbaum S., and Chaudhuri G. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-l-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res. 60 12 (2000) 3305-3312
12. Morales-Ruiz M., Fulton D., Sowa G., Languino L.R., Fujio Y., Walsh K., and Sessa W.C. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ. Res. 86 8 (2000) 892-896
13. Pervin S., Singh R., Hernandez E., Wu G., and Chaudhuri G. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Cancer Res. 67 1 (2007) 289-299
14. Pervin S., Singh R., and Chaudhuri G. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc. Natl. Acad. Sci. USA 98 6 (2001) 3583-3588
15. Pervin S S., Singh R., Freije W.A., and Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res. 63 24 (2003) 8853-8860
16. Pervin S S., Singh R., and Chaudhuri G. Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. Cancer Res. 63 17 (2003) 5470-5479
17. Pervin S., Tran A.H., Zekavati S., Fukuto J.M., Singh R., and Chaudhuri G. Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis. Cancer Res. 68 12 (2008) 1-13
18. Thomas D.D., Espey M.G., Ridnour L.A., Hofseth L.J., Mancardi D., Harris C.C., and Wink D.A. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc. Natl. Acad. Sci. USA 101 24 (2004) 8894-8899
19. Prueitt R.L., Boersma B.J., Howe T.M., Goodman J.E., Thomas D.D., Ying L., Pfiester C.M., Yfantis H.G., Cottrell J.R., Lee D.H., Remaley A.T., Hofseth L.J., Wink D.A., and Ambs S. Inflammation and IGF-I activate the Akt pathway in breast cancer. Int. J. Cancer 120 4 (2007) 796-805
20. Buga G.M., Wei L.H., Bauer P.M., Fukuto J.M., and Ignarro L.J. NG-hydroxy-l-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. 275 4 Pt 2 (1998) R1256-R1264
21. Singh R., Pervin S., and Chaudhuri G. Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-l-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of l-ornithine. J. Biol. Chem. 277 40 (2002) 37630-37636
22. Singh R., Pervin S., Wu G., and Chaudhuri G. Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-l-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines. Carcinogenesis 22 11 (2001) 1863-1869